SCHEMBL1979473

SCHEMBL1979473

COc1cc(CN2CC(C(=O)OC(=O)C3CN(Cc4ccc(OCCCCCCc5ccccc5)c(-c5cccs5)c4)C3)C2)cc(-c2cccs2)c1OCCCCCc1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 8/20 0.42
S1PR5 Q9H228 6/20 0.42
S1PR4 O95977 2/20 0.41
S1PR3 Q99500 2/20 0.38
PDCD1 Q15116 1/20 0.37
CD274 Q9NZQ7 1/20 0.37
SLC6A9 P48067 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
LMNA P02545 1/20 0.37
PDE4A P27815 1/20 0.37
PDE4B Q07343 1/20 0.37
PDE4C Q08493 1/20 0.37
PDE4D Q08499 1/20 0.37
SIGMAR1 Q99720 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1979472 0.95 S1PR1 (0.47) S1PR1S1PR5S1PR4S1PR3PDCD1
SCHEMBL1978012 0.90 S1PR1 (0.46) S1PR1S1PR5S1PR4S1PR3PDCD1
SCHEMBL1977547 0.86 S1PR1 (0.51) S1PR1S1PR5S1PR4S1PR3
SCHEMBL1978561 0.86 S1PR1 (0.51) S1PR1S1PR5S1PR4S1PR3
SCHEMBL1981594 0.79 S1PR1 (0.49) S1PR1S1PR5S1PR4S1PR3SIGMAR1
SCHEMBL1978057 0.76 S1PR5 (0.48) S1PR1S1PR5S1PR4S1PR3SLC6A9
SCHEMBL1978594 0.76 S1PR1 (0.46) S1PR1S1PR5S1PR4S1PR3
SCHEMBL1981574 0.76 SLC6A9 (0.50) S1PR1S1PR5S1PR4S1PR3SLC6A9
SCHEMBL1981219 0.75 S1PR1 (0.49) S1PR1S1PR5S1PR4S1PR3
SCHEMBL1978218 0.75 S1PR5 (0.55) S1PR1S1PR5S1PR4S1PR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2504328-A1 NOVEL COMPOUNDS AS RECEPTOR MODULATORS WITH THERAPEUTIC UTILITY Allergan, Inc. (US) 2012-10-03 EP claimed
WO-2011066179-A1 NOVEL COMPOUNDS AS RECEPTOR MODULATORS WITH THERAPEUTIC UTILITY ALLERGAN, INC. (US) 2011-06-03 WO claimed